Senior insider sale
President & CEO at SIONNA THERAPEUTICS, INC. — senior position signals high conviction
$5.92M
200K shares
CLOONAN MICHAEL plans to sell 200K shares of SIONNA THERAPEUTICS, INC. valued at approximately $5.92M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Exercise of Stock Options
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/21/2025 | Exercise of Stock Options Cash | 99.80K | — |
| Total | 99.80K | ||
Completed
Units to sell
10.43K
Market value
$328.5K
Units to sell
14.78K
Market value
$459.7K
Units to sell
7.79K
Market value
$231.5K
Units to sell
17.21K
Market value
$496.3K
Units to sell
7.43K
Market value
$185.7K
Units to sell
17.57K
Market value
$438.7K
Units to sell
25K
Market value
$568.7K
Planned — Approximate Date
Units to sell
99.80K
Market value
$3.21M
Units
200K
Value
$5.92M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/16/2025 | 10.43K | $328.5K | — | Completed |
10/15/2025 | 14.78K | $459.7K | — | Completed |
9/29/2025 | 7.79K | $231.5K | — | Completed |
9/26/2025 | 17.21K | $496.3K | — | Completed |
8/27/2025 | 7.43K | $185.7K | — | Completed |
8/26/2025 | 17.57K | $438.7K | — | Completed |
8/20/2025 | 25K | $568.7K | — | Completed |
| Planned — Approximate Date | ||||
10/21/2025 | 99.80K | $3.21M | NASDAQ | Planned |
| Total | 200K | $5.92M | ||